Didanosine

Didanosine

SCHEMBL7907418

O.OC[C@@H]1CC[C@H](n2cnc3c(O)ncnc32)O1.[NaH]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

pol

The experimentally established mechanism targets of Didanosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
LMNA P02545 1/20 0.59
ALB P02768 1/20 0.59
MAPK1 P28482 1/20 0.59
ABL1 P00519 2/20 0.46
RIN1 Q13671 2/20 0.46
ADA P00813 1/20 0.46
CYP1A2 P05177 1/20 0.45
HIF1A Q16665 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Didanosine SCHEMBL7910803 0.99 ALDH1A1 (0.60) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL8709115 0.99 ALDH1A1 (0.60) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL7907423 0.97 ALDH1A1 (0.59) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL1769151 0.97 ALDH1A1 (0.61) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL3364 0.97 ALDH1A1 (0.61) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL12150307 0.97 ALDH1A1 (0.61) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL29387997 0.97 ALDH1A1 (0.61) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL7910809 0.96 ALDH1A1 (0.60) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL9223571 0.92 ALDH1A1 (0.56) ALDH1A1LMNAALBMAPK1ABL1
Didanosine SCHEMBL8025110 0.92 ALDH1A1 (0.58) ALDH1A1LMNAALBMAPK1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207650-B1 USEFUL AS INTERMEDIATES OR AS ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY 2001-03-27 US claimed
EP-0398230-B1 Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate BRISTOL MYERS SQUIBB CO (US) 1998-01-21 EP claimed